Summary: Researchers have developed a new method for evaluating drug safety. The test is able to detect stress on cells at an earlier stage than current methods that rely on detecting cell death.
Source: Penn State.
A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death. The new method uses a fluorescent sensor that is turned on in a cell when misfolded proteins begin to aggregate — an early sign of cellular stress. The method can be adapted to detect protein aggregates caused by other toxins, as well as diseases such as Alzheimer’s or Parkinson’s. A paper describing the new method, by a team of researchers at Penn State University, appears in the journal Angewandte Chemie International Edition.
“Drug-induced protein stress in cells is a key factor in determining drug safety,” said Xin Zhang, assistant professor of chemistry and of biochemistry and molecular biology at Penn State, the senior author of the paper. “Drugs can cause proteins — which are long strings of amino acids that need to be precisely folded to function properly — to misfold and clump together into aggregates that can eventually kill the cell. We set out to develop a system that can detect these aggregates at very early stages and that also uses technology that is affordable and accessible to many laboratories.”
The new system is the first to use a fluorescent sensor that is not turned on until the misfolded proteins begin to aggregate. The researchers designed an unstable protein — called AgHalo — that is tagged with a special fluorescent dye that becomes active in a hydrophobic, i.e. water-repellent, environment. Hydrophobic portions of proteins are usually buried deep in the structure of a properly-folded protein because the environment of the cell is mostly water. When the AgHalo protein begins to misfold and aggregate the dye can interact with the hydrophobic portions of the protein and begin to fluoresce.
Previous systems used sensors that were always on. The cells would have a general diffuse fluorescence prior to any stress and the systems could only detect proteins stress when the misfolded proteins aggregated, forming brighter spots of fluorescence that were large enough to be seen under a microscope.
“An additional advantage of our system is that the level of fluorescence is correlated to the amount of protein aggregation in the cell, so we can quantify the level of stress” said Yu Liu, a postdoctoral researcher at Penn State and the first author of the paper. “Also, because our method measures the level of fluorescence, rather than having to identify the fluorescence under a microscope, it can be done using more accessible technology, like plate readers, and it is much more high-throughput.”
The researchers used their sensor to test the level of protein stress caused by five commonly-used anti-cancer drugs. Although none of the drugs they test cause significant cell death in previous drug safety tests, all five produced some level of protein stress detectable by the AgHalo sensor.
Image of cells expressing the AgHalo sensor before (left) and after (right) cellular stress. The AgHalo sensor is turned on when misfolded proteins begin to aggregate and provides a quantitative measure of cellular stress that can be used to evaluate drug safety. NeuroscienceNews.com image is credited to Yu Liu, Penn State University.
Protein stress can be induced by other many factors. Heat, toxins, bacterial infections, cancer, and even aging can cause proteins to misfold and form aggregates in cells. “With our method, we can quantitatively detect protein stress in cells at much earlier stages and therefore researchers can begin to study the mechanisms that cells use to combat this stress and develop compounds that can enhance the cell’s ability to handle protein stress,” said Zhang.
Funding: In addition to Zhang, the research team includes Yu Liu, Matthew Fares, Noah P. Dunham, Zi Gao, Kun Miao, Xuenyuan Jiang, Samuel S. Bollinger, and Amie K Boal at Penn State. The research was funded a Burroughs Wellcome Fund Career Award at the Scientific Interface, the Paul Berg Early Career Professorship, the Lloyd and Dottie Huck Early Career Award, the U.S. National Institutes of Health, and the Searle Scholars Program. Additional support was provided by the Huck Institute for the Life Sciences at Penn State.
Source: Barbara Kennedy – Penn State
Image Source: NeuroscienceNews.com image is credited to Yu Liu, Penn State University.
Original Research: Abstract for “AgHalo: A Facile Fluorogenic Sensor to Detect Drug-Induced Proteome Stress” by Dr. Yu Liu, Matthew Fares, Noah P. Dunham, Zi Gao, Kun Miao, Xueyuan Jiang, Samuel S. Bollinger, Prof. Amie K. Boal, and Prof. Xin Zhang in Angewandte Chemie International Edition. Published online July 19 2017 doi:10.1002/ange.201702417
[cbtabs][cbtab title=”MLA”]Penn State “More Sensitive Sensor for Evaluating Drug Safety.” NeuroscienceNews. NeuroscienceNews, 4 August 2017.
<https://neurosciencenews.com/drug-safety-testing-7245/>.[/cbtab][cbtab title=”APA”]Penn State (2017, August 4). More Sensitive Sensor for Evaluating Drug Safety. NeuroscienceNew. Retrieved August 4, 2017 from https://neurosciencenews.com/drug-safety-testing-7245/[/cbtab][cbtab title=”Chicago”]Penn State “More Sensitive Sensor for Evaluating Drug Safety.” https://neurosciencenews.com/drug-safety-testing-7245/ (accessed August 4, 2017).[/cbtab][/cbtabs]
Abstract
AgHalo: A Facile Fluorogenic Sensor to Detect Drug-Induced Proteome Stress
Drug-induced proteome stress that involves protein aggregation may cause adverse effects and undermine the safety profile of a drug. Safety of drugs is regularly evaluated using cytotoxicity assays that measure cell death. However, these assays provide limited insights into the presence of proteome stress in live cells. A fluorogenic protein sensor is reported to detect drug-induced proteome stress prior to cell death. An aggregation prone Halo-tag mutant (AgHalo) was evolved to sense proteome stress through its aggregation. Detection of such conformational changes was enabled by a fluorogenic ligand that fluoresces upon AgHalo forming soluble aggregates. Using 5 common anticancer drugs, we exemplified detection of differential proteome stress before any cell death was observed. Thus, this sensor can be used to evaluate drug safety in a regime that the current cytotoxicity assays cannot cover and be generally applied to detect proteome stress induced by other toxins.
“AgHalo: A Facile Fluorogenic Sensor to Detect Drug-Induced Proteome Stress” by Dr. Yu Liu, Matthew Fares, Noah P. Dunham, Zi Gao, Kun Miao, Xueyuan Jiang, Samuel S. Bollinger, Prof. Amie K. Boal, and Prof. Xin Zhang in Angewandte Chemie International Edition. Published online July 19 2017 doi:10.1002/ange.201702417
